CEO
Fabian Tenenbaum
Employees
27
Industry
Pharmaceutical Preparation Manufacturing
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Loading...
Open
0.04
Mkt cap
453K
Volume
109
High
0.04
P/E Ratio
-0.04
52-wk high
0.10
Low
0.04
Div yield
N/A
52-wk low
0.03
Portfolio Pulse from Benzinga Insights
October 13, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
October 13, 2023 | 5:31 pm
Portfolio Pulse from Lisa Levin
October 13, 2023 | 1:48 pm
Portfolio Pulse from Benzinga Insights
October 13, 2023 | 1:06 pm
Portfolio Pulse from Benzinga Insights
October 12, 2023 | 9:32 pm
Portfolio Pulse from Benzinga Insights
October 10, 2023 | 5:09 pm
Portfolio Pulse from Benzinga Insights
July 28, 2023 | 4:36 pm
Portfolio Pulse from Benzinga Insights
July 28, 2023 | 1:06 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.